VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 264 filers reported holding VAXCYTE INC in Q2 2024. The put-call ratio across all filers is 0.45 and the average weighting 0.6%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 793,036 | $59,882,148 | 46.04% |
Darwin Global Management, Ltd. | 2,080,946 | $163,916,116 | 19.07% |
RA Capital Management | 8,203,754 | $619,465,465 | 8.19% |
ACUTA CAPITAL PARTNERS, LLC | 110,400 | $8,336,304 | 7.02% |
COMMODORE CAPITAL LP | 1,305,000 | $98,540,550 | 6.73% |
Saturn V Capital Management LP | 215,680 | $16,285,997 | 6.15% |
Cormorant Asset Management, LP | 1,100,000 | $83,061,000 | 4.80% |
Kynam Capital Management, LP | 753,240 | $56,877,152 | 4.39% |
Novo Holdings A/S | 950,000 | $71,734,500 | 4.16% |
Frazier Life Sciences Management, L.P. | 1,039,405 | $78,485,472 | 3.67% |